Quick Answer
LakeShore Biopharma Co., Ltd. reported Total Assets of $190.53 million for fiscal year 2025.
LakeShore Biopharma Co., Ltd. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $190.53M | -87.4% |
| 2024 | $1.51B | -12.0% |
| 2023 | $1.72B | +19.3% |
| 2022 | $1.44B | — |
- LakeShore Biopharma Co., Ltd. showed a decrease of -87.4% in Total Assets compared to the prior fiscal year.
- Over the 2022–2025 period, LakeShore Biopharma Co., Ltd.’s total assets has declined by 86.8% (from $1.44 billion to $190.53 million).
- The most recent figure is from LakeShore Biopharma Co., Ltd.’s fiscal year 2025 report (Form 20-F), filed with the SEC on July 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: